πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

11 results for β€œthalidomide” Clear

  1. Ixazomib, thalidomide, & dexamethasone (ITD) re-induction

    Takeda Pharmaceuticals International AG

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  2. Thalidomide

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  3. Two Anti-angiogenesis Drugs（Endostar and ThalidomideοΌ‰

    First Tracks Biotherapeutics

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  4. glutamine combined with thalidomide

    China SXT Pharmaceuticals

    Mucositis Oral

    phase 3 small molecule completed

    1 trial

  5. Luspatercept combined with low-dose thalidomide

    First Tracks Biotherapeutics

    Transfusion-dependent Ξ²-thalassemia Patients

    phase 2 small molecule active

    1 trial

  6. Thalidomide and methotrexate

    China SXT Pharmaceuticals

    T-LGL Leukemia

    phase 2 small molecule active

    1 trial

  7. placebo

    First Tracks Biotherapeutics

    COVID-19 Thalidomide

    phase 2 small molecule active

    1 trial

  8. thalidomide

    Ultragenyx UK Limited

    HIV Infections

    phase 2 small molecule completed

    1 trial

  9. Camrelizumab + chemotherapy+Thalidomide

    China SXT Pharmaceuticals

    Lung Cancer

    approved small molecule active

    1 trial

  10. Thalidomide

    First Tracks Biotherapeutics

    Gastric Cancer

    approved small molecule active

    1 trial

  11. Thalidomide

    First Tracks Biotherapeutics

    Hepatocellular Carcinoma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources